{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:11:18Z","timestamp":1787238678603,"version":"build-2736575974"},"reference-count":131,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.jns.2021.120016","type":"journal-article","created":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T01:16:54Z","timestamp":1633051014000},"page":"120016","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Parkinsonism and dystonia: Clinical spectrum and diagnostic clues"],"prefix":"10.1016","volume":"433","author":[{"given":"Hugo","family":"Morales-Briceno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor S.C.","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailash P.","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Balint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jns.2021.120016_bb0005","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41572-018-0023-6","article-title":"Dystonia","volume":"4","author":"Balint","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.jns.2021.120016_bb0010","doi-asserted-by":"crossref","first-page":"104462","DOI":"10.1016\/j.nbd.2019.05.001","article-title":"Dystonia and Parkinson\u2019s disease: what is the relationship?","volume":"132","author":"Shetty","year":"2019","journal-title":"Neurobiol. Dis."},{"issue":"7","key":"10.1016\/j.jns.2021.120016_bb0015","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/mds.25475","article-title":"Phenomenology and classification of dystonia: a consensus update","volume":"28","author":"Albanese","year":"2013","journal-title":"Mov. Disord."},{"issue":"12","key":"10.1016\/j.jns.2021.120016_bb0020","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"issue":"7","key":"10.1016\/j.jns.2021.120016_bb0025","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/mds.25549","article-title":"Assessment of patients with isolated or combined dystonia: an update on dystonia syndromes","volume":"28","author":"Fung","year":"2013","journal-title":"Mov. Disord."},{"issue":"8","key":"10.1016\/j.jns.2021.120016_bb0030","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1002\/mds.23548","article-title":"Parkinsonism and dystonia associated with adalimumab","volume":"26","author":"Ha","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2021.120016_bb0035","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jns.2017.01.043","article-title":"Cyclosporine a induced dystonia-parkinsonism","volume":"375","author":"Miklav\u010di\u010d","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2021.120016_bb0040","doi-asserted-by":"crossref","first-page":"652","DOI":"10.3389\/fneur.2019.00652","article-title":"Infectious etiologies of parkinsonism: Pathomechanisms and clinical implications","volume":"10","author":"Limphaibool","year":"2019","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2021.120016_bb0045","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4103\/0028-3886.152678","article-title":"Subacute sclerosing panencephalitis masquerading as rapid-onset dystonia-parkinsonism in a child","volume":"63","author":"Kannan","year":"2015","journal-title":"Neurol. India"},{"issue":"Pt 11","key":"10.1016\/j.jns.2021.120016_bb0075","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1093\/brain\/aws256","article-title":"Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders","volume":"135","author":"Dale","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.jns.2021.120016_bb0080","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.parkreldis.2021.05.026","article-title":"Movement disorders in systemic autoimmune diseases: clinical spectrum, ancillary investigations, pathophysiological considerations","volume":"88","author":"Menozzi","year":"2021","journal-title":"Parkinsonism Relat. Disord."},{"issue":"6","key":"10.1016\/j.jns.2021.120016_bb0085","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1136\/jnnp-2018-318584","article-title":"The movement disorder associated with NMDAR antibody-encephalitis is complex and characteristic: an expert video-rating study","volume":"90","author":"Varley","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"15","key":"10.1016\/j.jns.2021.120016_bb0090","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.2169\/internalmedicine.54.3757","article-title":"An atypical case of anti-NMDA receptor encephalitis: predominant parkinsonism and persisting Micrographia without Oro-facial dyskinesia","volume":"54","author":"Kadoya","year":"2015","journal-title":"Intern. Med."},{"issue":"2","key":"10.1016\/j.jns.2021.120016_bb0095","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/mds.23315","article-title":"Isolated hemidystonia associated with NMDA receptor antibodies","volume":"26","author":"Rubio-Agust\u00ed","year":"2011","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.jns.2021.120016_bb0100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/brain\/awx189","article-title":"Movement disorders with neuronal antibodies: syndromic approach, genetic parallels and pathophysiology","volume":"141","author":"Balint","year":"2017","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.jns.2021.120016_bb0105","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1212\/WNL.46.1.68","article-title":"Delayed-onset progressive movement disorders after static brain lesions","volume":"46","author":"Scott","year":"1996","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jns.2021.120016_bb0110","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/mds.22415","article-title":"Hemidystonia-hemiatrophy syndrome","volume":"24","author":"Wijemanne","year":"2009","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.jns.2021.120016_bb0115","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/1531-8257(200005)15:3<537::AID-MDS1018>3.0.CO;2-3","article-title":"Parkinsonism, dystonia, and hemiatrophy","volume":"15","author":"Greene","year":"2000","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.jns.2021.120016_bb0120","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/brain\/awz345","article-title":"Clinical and neuroimaging phenotypes of genetic parkinsonism from infancy to adolescence","volume":"143","author":"Morales-Brice\u00f1o","year":"2020","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.jns.2021.120016_bb0125","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nrneurol.2015.172","article-title":"Monoamine neurotransmitter disorders--clinical advances and future perspectives","volume":"11","author":"Ng","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jns.2021.120016_bb0130","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jns.2017.06.034","article-title":"Exome sequencing results in identification and treatment of brain dopamine-serotonin vesicular transport disease","volume":"379","author":"Rath","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2021.120016_bb0135","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/B978-0-444-63233-3.00019-1","article-title":"Neurodegeneration with brain iron accumulation","volume":"147","author":"Hayflick","year":"2018","journal-title":"Handb. Clin. Neurol."},{"issue":"14","key":"10.1016\/j.jns.2021.120016_bb0140","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/mds.25622","article-title":"Early onset dystonia and parkinsonism with abnormal globus pallidal signal in MRI: a diagnostic challenge","volume":"28","author":"Post","year":"2013","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.jns.2021.120016_bb0145","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ajhg.2012.01.017","article-title":"Mutations in SLC30A10 cause parkinsonism and dystonia with hypermanganesemia, polycythemia, and chronic liver disease","volume":"90","author":"Quadri","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jns.2021.120016_bb0150","doi-asserted-by":"crossref","first-page":"11601","DOI":"10.1038\/ncomms11601","article-title":"Mutations in SLC39A14 disrupt manganese homeostasis and cause childhood-onset parkinsonism-dystonia","volume":"7","author":"Tuschl","year":"2016","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.jns.2021.120016_bb0155","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/mdc3.12861","article-title":"Hypermanganesemia with Dystonia 1: a novel mutation and response to Iron supplementation","volume":"7","author":"Yapici","year":"2020","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.jns.2021.120016_bb0160","first-page":"2(2)","article-title":"Magnetic resonance imaging pattern recognition in childhood bilateral basal ganglia disorders","author":"Mohammad","year":"2020","journal-title":"Brain Commun."},{"issue":"1\u20132","key":"10.1016\/j.jns.2021.120016_bb0165","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jns.2014.03.057","article-title":"Inherited manganism: the \u201ccock-walk\u201d gait and typical neuroimaging features","volume":"341","author":"Avelino","year":"2014","journal-title":"J. Neurol. Sci."},{"issue":"Pt 3","key":"10.1016\/j.jns.2021.120016_bb0170","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/brain\/awl340","article-title":"The phenotypic spectrum of rapid-onset dystonia-parkinsonism (RDP) and mutations in the ATP1A3 gene","volume":"130","author":"Brashear","year":"2007","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.jns.2021.120016_bb0175","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/mds.27801","article-title":"Revising rapid-onset dystonia-parkinsonism: broadening indications for ATP1A3 testing","volume":"34","author":"Haq","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2021.120016_bb0180","first-page":"9","article-title":"Generalized Dystonia and paroxysmal dystonic attacks due to a novel ATP1A3 variant","author":"Z\u00fa\u00f1iga-Ram\u00edrez","year":"2019","journal-title":"Tremor. Other Hyperkinet. Mov. (N Y)"},{"issue":"4","key":"10.1016\/j.jns.2021.120016_bb0185","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.braindev.2020.12.009","article-title":"Rapid-onset dystonia-parkinsonism with ATP1A3 mutation and left lower limb paroxysmal dystonia","volume":"43","author":"Nomura","year":"2021","journal-title":"Brain and Development"},{"issue":"4","key":"10.1016\/j.jns.2021.120016_bb0190","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/mdc3.12747","article-title":"Paroxysmal asymmetric dystonic arm posturing\u2014a less recognized but characteristic manifestation of ATP1A3-related disease","volume":"6","author":"Balint","year":"2019","journal-title":"Move. Disord. Clin. Pract."},{"key":"10.1016\/j.jns.2021.120016_bb0195","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.parkreldis.2018.10.013","article-title":"PLA2G6-associated neurodegeneration: new insights into brain abnormalities and disease progression","volume":"61","author":"Darling","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jns.2021.120016_bb0200","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1002\/mds.28517","article-title":"Genotype\u2013phenotype relations for the atypical parkinsonism genes: MDSGene systematic review","volume":"36","author":"Wittke","year":"2021","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.jns.2021.120016_bb0205","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1212\/01.wnl.0000338144.10967.2b","article-title":"FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome","volume":"72","author":"Di Fonzo","year":"2009","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.jns.2021.120016_bb0210","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/mds.28063","article-title":"DNAJC6 mutations disrupt dopamine homeostasis in juvenile parkinsonism-Dystonia","volume":"35","author":"Ng","year":"2020","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.jns.2021.120016_bb0215","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.parkreldis.2012.11.006","article-title":"DNAJC6 is responsible for juvenile parkinsonism with phenotypic variability","volume":"19","author":"K\u00f6ro\u011flu","year":"2013","journal-title":"Parkinsonism Relat. Disord."},{"issue":"9","key":"10.1016\/j.jns.2021.120016_bb0220","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/mds.22876","article-title":"Neuronal intranuclear inclusion disease: two cases of dopa-responsive juvenile parkinsonism with drug-induced dyskinesia","volume":"25","author":"Lai","year":"2010","journal-title":"Mov. Disord."},{"issue":"Pt 9","key":"10.1016\/j.jns.2021.120016_bb0225","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1093\/brain\/aww180","article-title":"Loss of SYNJ1 dual phosphatase activity leads to early onset refractory seizures and progressive neurological decline","volume":"139","author":"Hardies","year":"2016","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.jns.2021.120016_bb0230","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/humu.22372","article-title":"The Sac1 domain of SYNJ1 identified mutated in a family with early-onset progressive parkinsonism with generalized seizures","volume":"34","author":"Krebs","year":"2013","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.jns.2021.120016_bb0235","first-page":"12(366)","article-title":"Clinical Variability of SYNJ1-Associated Early-Onset Parkinsonism","author":"Lesage","year":"2021","journal-title":"Front. Neurol."},{"issue":"3","key":"10.1016\/j.jns.2021.120016_bb0240","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/mds.26876","article-title":"Novel compound heterozygous synaptojanin-1 mutation causes l-dopa-responsive dystonia-parkinsonism syndrome","volume":"32","author":"Rauschendorf","year":"2017","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.jns.2021.120016_bb0245","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(08)70022-X","article-title":"DYT16, a novel young-onset dystonia-parkinsonism disorder: identification of a segregating mutation in the stress-response protein PRKRA","volume":"7","author":"Camargos","year":"2008","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.jns.2021.120016_bb0250","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/mds.26583","article-title":"PRKRA mutation causing early-onset generalized Dystonia-parkinsonism (DYT16) in an Italian family","volume":"31","author":"Quadri","year":"2016","journal-title":"Mov. Disord."},{"issue":"12","key":"10.1016\/j.jns.2021.120016_bb0255","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/mds.25981","article-title":"DYT16 revisited: exome sequencing identifies PRKRA mutations in a European dystonia family","volume":"29","author":"Zech","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2021.120016_bb0260","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/mds.28485","article-title":"Genotype\u2013phenotype relations for isolated dystonia genes: MDSGene systematic review","volume":"36","author":"Lange","year":"2021","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.jns.2021.120016_bb0265","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1002\/mds.28492","article-title":"PRKRA-related disorders: bilateral striatal degeneration in addition to DYT16 Spectrum","volume":"36","author":"Masnada","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2021.120016_bb0270","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.parkreldis.2020.08.039","article-title":"Movement disorders in ADAR1 disease: insights from a comprehensive cohort","volume":"79","author":"Di Lazzaro","year":"2020","journal-title":"Parkinsonism Relat. Disord."},{"issue":"5","key":"10.1016\/j.jns.2021.120016_bb0275","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s10072-018-3247-z","article-title":"Novel SERAC1 mutations in a Chinese patient presenting with parkinsonism and dystonia","volume":"39","author":"Ma","year":"2018","journal-title":"Neurol. Sci."},{"issue":"10","key":"10.1016\/j.jns.2021.120016_bb0280","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/mds.25008","article-title":"Reversible generalized dystonia and encephalopathy from thiamine transporter 2 deficiency","volume":"27","author":"Serrano","year":"2012","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.jns.2021.120016_bb0285","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10048-019-00602-4","article-title":"POLR3A variants with striatal involvement and extrapyramidal movement disorder","volume":"21","author":"Harting","year":"2020","journal-title":"Neurogenetics"},{"issue":"3","key":"10.1016\/j.jns.2021.120016_bb0290","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/cge.13172","article-title":"Biallelic mutations in mitochondrial tryptophanyl-tRNA synthetase cause levodopa-responsive infantile-onset parkinsonism","volume":"93","author":"Burke","year":"2018","journal-title":"Clin. Genet."},{"issue":"4","key":"10.1016\/j.jns.2021.120016_bb0295","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1017\/cjn.2016.8","article-title":"The incidence and evolution of Parkinsonian rigidity in Rett syndrome: a pilot study","volume":"43","author":"Humphreys","year":"2016","journal-title":"Can. J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.jns.2021.120016_bb0300","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/mdc3.12865","article-title":"Parkinsonism, intellectual disability, and catatonia in a young male with MECP2 variant","volume":"7","author":"Pollini","year":"2020","journal-title":"Mov. Disord. Clin. Pract."},{"issue":"1","key":"10.1016\/j.jns.2021.120016_bb0305","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/mds.23956","article-title":"Generalized dystonia, athetosis, and parkinsonism associated with FOXG1 mutation","volume":"27","author":"M\u00e9neret","year":"2012","journal-title":"Mov. Disord."},{"issue":"11","key":"10.1016\/j.jns.2021.120016_bb0310","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1002\/mds.27501","article-title":"PTRHD1 loss-of-function mutation in an african family with juvenile-onset parkinsonism and intellectual disability","volume":"33","author":"Kuipers","year":"2018","journal-title":"Mov. Disord."},{"issue":"12","key":"10.1016\/j.jns.2021.120016_bb0315","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.parkreldis.2015.10.001","article-title":"A splice site mutation in ATP6AP2 causes X-linked intellectual disability, epilepsy, and parkinsonism","volume":"21","author":"Gupta","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"issue":"12","key":"10.1016\/j.jns.2021.120016_bb0320","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/mds.26828","article-title":"A novel RAB39B gene mutation in X-linked juvenile parkinsonism with basal ganglia calcification","volume":"31","author":"Shi","year":"2016","journal-title":"Mov. Disord."},{"issue":"8","key":"10.1016\/j.jns.2021.120016_bb0325","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1002\/ajmg.a.38288","article-title":"Haploinsufficiency of NR4A2 is associated with a neurodevelopmental phenotype with prominent language impairment","volume":"173","author":"Reuter","year":"2017","journal-title":"Am. J. Med. Genet. A"},{"issue":"5","key":"10.1016\/j.jns.2021.120016_bb0330","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/mds.27982","article-title":"Loss-of-function mutations in NR4A2 cause Dopa-responsive Dystonia parkinsonism","volume":"35","author":"Wirth","year":"2020","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.jns.2021.120016_bb0335","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000543","article-title":"NR4A2 mutations can cause intellectual disability and language impairment with persistent Dystonia-parkinsonism","volume":"7","author":"Jes\u00fas","year":"2021","journal-title":"Neurol. Genet."},{"issue":"1","key":"10.1016\/j.jns.2021.120016_bb0340","doi-asserted-by":"crossref","first-page":"104123","DOI":"10.1016\/j.ejmg.2020.104123","article-title":"Early-onset parkinsonism in PPP2R5D-related neurodevelopmental disorder","volume":"64","author":"Hetzelt","year":"2021","journal-title":"Eur. J. Med. Genet."},{"issue":"5","key":"10.1016\/j.jns.2021.120016_bb0345","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/ana.25863","article-title":"Early-onset parkinsonism is a manifestation of the PPP2R5D p.E200K mutation","volume":"88","author":"Kim","year":"2020","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2021.120016_bb0350","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ajhg.2017.07.002","article-title":"Heterozygous De novo UBTF gain-of-function variant is associated with Neurodegeneration in childhood","volume":"101","author":"Edvardson","year":"2017","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.jns.2021.120016_bb0355","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12883-019-1586-x","article-title":"Childhood neurodegeneration associated with a specific UBTF variant: a new case report and review of the literature","volume":"20","author":"Bastos","year":"2020","journal-title":"BMC Neurol."},{"issue":"3","key":"10.1016\/j.jns.2021.120016_bb0360","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s10072-020-04758-y","article-title":"Recurrent de novo missense variant E210K in UBTF causes juvenile dystonia-parkinsonism","volume":"42","author":"Ikeda","year":"2021","journal-title":"Neurol. Sci."},{"issue":"2","key":"10.1016\/j.jns.2021.120016_bb0365","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/ana.25751","article-title":"Clinico-genetic, imaging and molecular delineation of COQ8A-Ataxia: a multicenter study of 59 patients","volume":"88","author":"Trasch\u00fctz","year":"2020","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2021.120016_bb0370","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/mdc3.12144","article-title":"SPG11 mutations associated with a complex phenotype resembling Dopa-responsive Dystonia","volume":"2","author":"Wijemanne","year":"2015","journal-title":"Mov. Disord. Clin. Pract."},{"issue":"2","key":"10.1016\/j.jns.2021.120016_bb0375","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00415-013-7216-4","article-title":"SPG15: a cause of juvenile atypical levodopa responsive parkinsonism","volume":"261","author":"Mallaret","year":"2014","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2021.120016_bb0380","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.parkreldis.2019.04.004","article-title":"Parkinsonism in PGK1 deficiency implicates the glycolytic pathway in nigrostriatal dysfunction","volume":"64","author":"Morales-Briceno","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"issue":"4","key":"10.1016\/j.jns.2021.120016_bb0385","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/mds.10677","article-title":"Chediak-Higashi syndrome with parkinsonism","volume":"19","author":"Silveira-Moriyama","year":"2004","journal-title":"Mov. Disord."},{"issue":"11","key":"10.1016\/j.jns.2021.120016_bb0390","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1007\/s00415-014-7483-8","article-title":"X-linked agammaglobulinemia with hearing impairment, dystonia-parkinsonism, and progressive neurodegeneration","volume":"261","author":"Domingo","year":"2014","journal-title":"J. Neurol."},{"issue":"24","key":"10.1016\/j.jns.2021.120016_bb0395","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1212\/WNL.0000000000000521","article-title":"Antecollis and levodopa-responsive parkinsonism are late features of Dravet syndrome","volume":"82","author":"Fasano","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2021.120016_bb0400","doi-asserted-by":"crossref","first-page":"553","DOI":"10.12688\/f1000research.10588.1","article-title":"Case Report: Novel mutations in TBC1D24 are associated with autosomal dominant tonic-clonic and myoclonic epilepsy and recessive Parkinsonism, psychosis, and intellectual disability","volume":"6","author":"Banuelos","year":"2017","journal-title":"F1000Res"},{"issue":"1","key":"10.1016\/j.jns.2021.120016_bb0405","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10048-014-0431-z","article-title":"A novel de novo STXBP1 mutation is associated with mitochondrial complex I deficiency and late-onset juvenile-onset parkinsonism","volume":"16","author":"Keogh","year":"2015","journal-title":"Neurogenetics"},{"issue":"9","key":"10.1016\/j.jns.2021.120016_bb0410","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.braindev.2020.06.011","article-title":"Fifteen-year follow-up of a patient with a DHDDS variant with non-progressive early onset myoclonic tremor and rare generalized epilepsy","volume":"42","author":"Togashi","year":"2020","journal-title":"Brain and Development"},{"issue":"2","key":"10.1016\/j.jns.2021.120016_bb0415","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1684\/epd.2020.1150","article-title":"Early parkinsonism in a Senegalese girl with Lafora disease","volume":"22","author":"Ragona","year":"2020","journal-title":"Epileptic Disord."},{"issue":"2","key":"10.1016\/j.jns.2021.120016_bb0420","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/mdc3.12573","article-title":"The Spectrum of movement disorders in childhood-onset Lysosomal storage diseases","volume":"5","author":"Ebrahimi-Fakhari","year":"2018","journal-title":"Mov. Disord. Clin. Pract."},{"issue":"1\u20132","key":"10.1016\/j.jns.2021.120016_bb0425","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jns.2015.05.021","article-title":"Protracted late infantile ceroid lipofuscinosis due to TPP1 mutations: clinical, molecular and biochemical characterization in three sibs","volume":"356","author":"Di Giacopo","year":"2015","journal-title":"J. Neurol. Sci."},{"issue":"4","key":"10.1016\/j.jns.2021.120016_bb0430","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ajhg.2020.02.016","article-title":"De novo EIF2AK1 and EIF2AK2 variants are associated with developmental delay, Leukoencephalopathy, and neurologic Decompensation","volume":"106","author":"Mao","year":"2020","journal-title":"Am. J. Hum. Genet."},{"issue":"12","key":"10.1016\/j.jns.2021.120016_bb0435","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1002\/mds.23221","article-title":"Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations","volume":"25","author":"Pais\u00e1n-Ruiz","year":"2010","journal-title":"Move. Disord.: Off. J. Move. Disord. Soc."},{"issue":"1","key":"10.1016\/j.jns.2021.120016_bb0440","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1468-1331.2008.02356.x","article-title":"R632W mutation in PLA2G6 segregates with dystonia-parkinsonism in a consanguineous Iranian family","volume":"16","author":"Sina","year":"2009","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2021.120016_bb0445","doi-asserted-by":"crossref","first-page":"317","DOI":"10.5334\/tohm.254","article-title":"PLA2G6-associated Dystonia-Parkinsonism: case report and literature review","volume":"5","author":"Karkheiran","year":"2015","journal-title":"Tremor. Other Hyperkinet. Mov. (N Y)"},{"issue":"1","key":"10.1016\/j.jns.2021.120016_bb0450","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12883-020-01684-6","article-title":"Genotype-phenotype correlations of adult-onset PLA2G6-associated Neurodegeneration: case series and literature review","volume":"20","author":"Chu","year":"2020","journal-title":"BMC Neurol."},{"issue":"11","key":"10.1016\/j.jns.2021.120016_bb0455","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/mds.28289","article-title":"Expanding data collection for the MDSGene database: X-linked Dystonia-parkinsonism as use case example","volume":"35","author":"Pauly","year":"2020","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.jns.2021.120016_bb0460","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/mdc3.12929","article-title":"Phasic knee bending dystonic and Parkinsonian gait: a characteristic finding in X-linked Dystonia parkinsonism","volume":"7","author":"Stephen","year":"2020","journal-title":"Move. Disord. Clin. Pract."},{"issue":"5","key":"10.1016\/j.jns.2021.120016_bb0465","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/mds.27352","article-title":"Genotype-phenotype relations for the Parkinson\u2019s disease genes Parkin, PINK1, DJ1: MDSGene systematic review","volume":"33","author":"Kasten","year":"2018","journal-title":"Mov. Disord."},{"issue":"7","key":"10.1016\/j.jns.2021.120016_bb0470","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1136\/jnnp-2013-307294","article-title":"Isolated limb dystonia as presenting feature of Parkin disease","volume":"85","author":"Elia","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.jns.2021.120016_bb0475","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/ana.25787","article-title":"Characterization of recessive Parkinson disease in a large multicenter study","volume":"88","author":"Lesage","year":"2020","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2021.120016_bb0480","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/mdc3.12008","article-title":"Atypical parkinsonism-Dystonia syndrome caused by a novel DJ1 mutation","volume":"1","author":"Bras","year":"2014","journal-title":"Move. Disord. Clin. Pract."},{"issue":"2","key":"10.1016\/j.jns.2021.120016_bb0485","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/mdc3.12586","article-title":"The \u201cstutter-step\u201d: a peculiar gait feature in advanced Huntington\u2019s disease and chorea-Acanthocytosis","volume":"5","author":"Termsarasab","year":"2018","journal-title":"Move. Disord. Clin. Pract."},{"issue":"1","key":"10.1016\/j.jns.2021.120016_bb0490","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3233\/JHD-160232","article-title":"A systematic review of the Huntington disease-like 2 phenotype","volume":"6","author":"Anderson","year":"2017","journal-title":"J. Huntingtons Dis."},{"issue":"4","key":"10.1016\/j.jns.2021.120016_bb0495","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1001\/jamaneurol.2014.3889","article-title":"Primary familial brain calcification with known gene mutations: a systematic review and challenges of phenotypic characterization","volume":"72","author":"Tadic","year":"2015","journal-title":"JAMA Neurol."},{"issue":"2","key":"10.1016\/j.jns.2021.120016_bb0500","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000399","article-title":"MYORG-related disease is associated with central pontine calcifications and atypical parkinsonism","volume":"6","author":"Chelban","year":"2020","journal-title":"Neurol. Genet."},{"key":"10.1016\/j.jns.2021.120016_bb0505","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.parkreldis.2020.07.027","article-title":"A compound heterozygous ALPL variant in a patient with dystonia-parkinsonism and hypointensity in basal ganglia: a case report","volume":"78","author":"Li","year":"2020","journal-title":"Parkinsonism Relat. Disord."},{"issue":"6","key":"10.1016\/j.jns.2021.120016_bb0510","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/mdc3.13009","article-title":"A novel phenotype associated with CaSR-related familial brain calcifications","volume":"7","author":"Scannapieco","year":"2020","journal-title":"Move. Disord. Clin. Pract."},{"key":"10.1016\/j.jns.2021.120016_bb0515","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.parkreldis.2018.07.006","article-title":"Movement disorders in cerebrotendinous xanthomatosis","volume":"58","author":"Stelten","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"issue":"10","key":"10.1016\/j.jns.2021.120016_bb0520","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/mds.23109","article-title":"Atypical parkinsonism with apraxia and supranuclear gaze abnormalities in type 1 Gaucher disease. Expanding the spectrum: case report and literature review","volume":"25","author":"Alonso-Canovas","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2021.120016_bb0525","doi-asserted-by":"crossref","first-page":"125273","DOI":"10.1155\/2015\/125273","article-title":"Parkinsonism in spinocerebellar ataxia","volume":"2015","author":"Park","year":"2015","journal-title":"Biomed. Res. Int."},{"issue":"7","key":"10.1016\/j.jns.2021.120016_bb0530","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/mds.27334","article-title":"Genotype-phenotype correlations, dystonia and disease progression in spinocerebellar ataxia type 14","volume":"33","author":"Chelban","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2021.120016_bb0535","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.parkreldis.2019.05.001","article-title":"Spinocerebellar ataxia 48 presenting with ataxia associated with cognitive, psychiatric, and extrapyramidal features: a report of two Italian families","volume":"65","author":"De Michele","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"issue":"12","key":"10.1016\/j.jns.2021.120016_bb0540","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1002\/mds.28290","article-title":"Parkinsonism and Nigrostriatal damage secondary to CSF1R-related primary Microgliopathy","volume":"35","author":"Bonvegna","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2021.120016_bb0545","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.parkreldis.2019.07.030","article-title":"Dystonia in atypical parkinsonian disorders","volume":"66","author":"Marsili","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"issue":"14","key":"10.1016\/j.jns.2021.120016_bb0550","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1002\/mds.26054","article-title":"The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases","volume":"29","author":"Respondek","year":"2014","journal-title":"Mov. Disord."},{"issue":"12","key":"10.1016\/j.jns.2021.120016_bb0555","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1002\/mds.27527","article-title":"Genotype-phenotype relations for the Parkinson\u2019s disease genes SNCA, LRRK2, VPS35: MDSGene systematic review","volume":"33","author":"Trinh","year":"2018","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.jns.2021.120016_bb0560","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153852","article-title":"Characterization of movement disorder phenomenology in genetically proven, familial Frontotemporal lobar degeneration: a systematic review and meta-analysis","volume":"11","author":"Gasca-Salas","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jns.2021.120016_bb0565","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/mds.28356","article-title":"A clinicopathologic study of movement disorders in Frontotemporal lobar degeneration","volume":"36","author":"de Pablo-Fern\u00e1ndez","year":"2021","journal-title":"Mov. Disord."},{"issue":"7","key":"10.1016\/j.jns.2021.120016_bb0570","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1136\/jnnp-2015-311311","article-title":"Left hand dystonia as a recurring feature of a family carrying C9ORF72 mutation","volume":"87","author":"Luzzi","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.jns.2021.120016_bb0575","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000575","article-title":"Expanding the spectrum of movement disorders associated with <em>C9orf72<\/em> hexanucleotide expansions","volume":"7","author":"Estevez-Fraga","year":"2021","journal-title":"Neurol. Genet."},{"issue":"4","key":"10.1016\/j.jns.2021.120016_bb0580","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3233\/JAD-180123","article-title":"Unusual clinical presentations challenging the early clinical diagnosis of Creutzfeldt-Jakob disease","volume":"64","author":"Baiardi","year":"2018","journal-title":"J. Alzheimers Dis."},{"issue":"4","key":"10.1016\/j.jns.2021.120016_bb0585","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/mdc3.12307","article-title":"Clinicopathological correlates in a PRNP P102L mutation carrier with rapidly progressing parkinsonism-dystonia","volume":"3","author":"Umeh","year":"2016","journal-title":"Mov. Disord. Clin. Pract."},{"issue":"3","key":"10.1016\/j.jns.2021.120016_bb0590","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10048-017-0518-4","article-title":"Rare causes of early-onset dystonia-parkinsonism with cognitive impairment: a de novo PSEN-1 mutation","volume":"18","author":"Carecchio","year":"2017","journal-title":"Neurogenetics"},{"issue":"10","key":"10.1016\/j.jns.2021.120016_bb0595","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/mds.27812","article-title":"Parkinsonism and spastic paraplegia type 7: expanding the spectrum of mitochondrial parkinsonism","volume":"34","author":"De la Casa-Fages","year":"2019","journal-title":"Mov. Disord."},{"issue":"Pt 10","key":"10.1016\/j.jns.2021.120016_bb0600","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1093\/brain\/aws224","article-title":"Genotype-phenotype correlations in spastic paraplegia type 7: a study in a large Dutch cohort","volume":"135","author":"van Gassen","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.jns.2021.120016_bb0605","first-page":"7615605","article-title":"CAPN1 variants as cause of hereditary spastic paraplegia type 76","volume":"2019","author":"Garcia-Berlanga","year":"2019","journal-title":"Case Rep. Neurol. Med."},{"issue":"6","key":"10.1016\/j.jns.2021.120016_bb0610","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1001\/jamaneurol.2016.0355","article-title":"Clinical, genetic, and radiological features of extrapyramidal movement disorders in mitochondrial disease","volume":"73","author":"Martikainen","year":"2016","journal-title":"JAMA Neurol."},{"issue":"6","key":"10.1016\/j.jns.2021.120016_bb0615","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/brain\/awz112","article-title":"Network localization of cervical dystonia based on causal brain lesions","volume":"142","author":"Corp","year":"2019","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.jns.2021.120016_bb0620","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1093\/brain\/awy161","article-title":"Localizing parkinsonism based on focal brain lesions","volume":"141","author":"Joutsa","year":"2018","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.jns.2021.120016_bb0625","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.09.016","article-title":"Acute onset Dystonia after infarction of premotor and supplementary motor cortex","volume":"24","author":"Dhakar","year":"2015","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"5","key":"10.1016\/j.jns.2021.120016_bb0630","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.09.028","article-title":"Early-onset dystonia after supplementary motor area infarction","volume":"23","author":"Nishimura","year":"2014","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"5","key":"10.1016\/j.jns.2021.120016_bb0635","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/jnnp.51.5.730","article-title":"Parkinsonian syndrome caused by a tumour of the left supplementary motor area","volume":"51","author":"Straube","year":"1988","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.jns.2021.120016_bb0640","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/mds.1193","article-title":"Primary central nervous system lymphoma in the SMA presenting as rapidly progressive parkinsonism","volume":"16","author":"Haussermann","year":"2001","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.jns.2021.120016_bb0645","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/brain\/awz344","article-title":"Evolving concepts on bradykinesia","volume":"143","author":"Bologna","year":"2020","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.jns.2021.120016_bb0650","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ana.24845","article-title":"Lesions causing freezing of gait localize to a cerebellar functional network","volume":"81","author":"Fasano","year":"2017","journal-title":"Ann. Neurol."},{"issue":"10","key":"10.1016\/j.jns.2021.120016_bb0655","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1093\/brain\/awz261","article-title":"Cerebral differences between dopamine-resistant and dopamine-responsive Parkinson\u2019s tremor","volume":"142","author":"Dirkx","year":"2019","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.jns.2021.120016_bb0660","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/mdc3.13140","article-title":"Parkinsonism and positive dopamine transporter imaging in a patient with a novel KMT2B variant","volume":"8","author":"Feuerstein","year":"2021","journal-title":"Mov. Disord. Clin. Pract."},{"issue":"10","key":"10.1016\/j.jns.2021.120016_bb0665","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1002\/mds.27771","article-title":"Frequency and phenotypic spectrum of KMT2B dystonia in childhood: a single-center cohort study","volume":"34","author":"Carecchio","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2021.120016_bb0670","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.parkreldis.2019.01.020","article-title":"Craniocervical dystonia with levodopa-responsive parkinsonism co-segregating with a pathogenic ANO3 mutation in a Taiwanese family","volume":"62","author":"Kuo","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"issue":"2","key":"10.1016\/j.jns.2021.120016_bb0675","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/mds.870010210","article-title":"Parkinsonism following dystonia in three patients","volume":"1","author":"Katchen","year":"1986","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2021.120016_bb0680","doi-asserted-by":"crossref","first-page":"117477","DOI":"10.1016\/j.jns.2021.117477","article-title":"Development of parkinsonism after long-standing cervical dystonia - a cohort","volume":"427","author":"Balint","year":"2021","journal-title":"J. Neurol. Sci."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X2102712X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X2102712X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:58:50Z","timestamp":1758383930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X2102712X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":131,"alternative-id":["S0022510X2102712X"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2021.120016","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parkinsonism and dystonia: Clinical spectrum and diagnostic clues","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2021.120016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120016"}}